[Times of Zambia] On February 22, 2016, the International Partnership for Microbicides (IPM) in Boston, USA, released the following: In an important scientific achievement for women's health, two large Phase III clinical trials -- The Ring Study and ASPIRE - have shown that a monthly vaginal ring containing the antiretroviral drug (ARV) dapivirine can safely help prevent HIV-1 infection in women.